抗菌、抗真菌、抗寄生虫和抗病毒药物 42503条(本栏目收费,不能显示细节,电话15274084725)
mutant selection window hypothesis, 871, 883 883
resistance and cross-resistance, 2134, 2135 2135
Delamanid, 2550–2558 2558
administration mode, 2553 2553
adverse reactions and toxicity, 2553–2555 2555
antimicrobial activity, 2550, 2551t 2551
chemical structure, 2550, 2550f 2550
clinical uses, 2556–2557 2557
drug interactions, 2553, 2555t 2555
excretion, 2553, 2554t 2554
mechanism of action, 2552–2553 2553
pharmacokinetics/pharmacodynamics, 2554
Delavirdine, 3959–3969 3969
administration mode, 3961 3961
adverse reactions and toxicity, 3965–3966 3966
antiviral activity, 3959 3959
chemical structure, 3959, 3959f 3959
clinical use, HIV-1 infection, 3959, 3966–3967 3967
didanosine, 3962, 3963, 3963t 3963
indinavir, 3963–3964, 3963t, 3964t 3964
drug interactions, 3963–3965, 3963t 3963
adefovir dipivoxil, 4340t 4340
amprenavir, 3964–3965, 4112–4113 4113
antacids, 3962, 3964t 3964